DNTH vs SRPT · rev $6.2M vs rev $1.90B
Dianthus Therapeutics Inc. (DNTH) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
DNTH currently screens at market cap $4.40B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the DNTH and SRPT stock pages for the full models.
Not investment advice.